VRAX
Virax Biolabs Group·NASDAQ
--
--(--)
--
--(--)
VRAX Filings
Filing Date
Form Description
Form Type
2026-01-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-31
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-31 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-31
Form EFFECT - Notice of Effectiveness
2025-12-31 ·
Form EFFECT - Notice of Effectiveness
2025-12-18
Form F-3 - Registration statement by foreign private issuers
2025-12-18 ·
Form F-3 - Registration statement by foreign private issuers
2025-12-18
Form D - Notice of Exempt Offering of Securities
2025-12-18 ·
Form D - Notice of Exempt Offering of Securities
2025-12-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-04 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-12-02 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-29
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-29 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-29
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-29 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-29
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-29 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
